MentionFox
Home › funding signals › Nok Therapeutics, Inc.
Company · SEC filings

Nok Therapeutics, Inc. funding history

Nok Therapeutics, Inc. has 8 Form D filings on record, from 2025-10-24 to 2026-05-01. Together its new offerings report $818K sold.

Funding historyFounders and team

What do you want to do with Nok Therapeutics, Inc.?

Based
CRANBERRY TWP., PENNSYLVANIA
Year formed
2024
Industry group
Biotechnology
Filings
8
Raised (new offerings)
$818K

Every filing

FiledTypeAmount soldTotal offeringRecords
2026-05-01Amendment
first sale 2024-09-24
$751K—SEC filing
2026-05-01Amendment
first sale 2024-06-11
$3K$3KSEC filing
2026-04-22Amendment
first sale 2024-08-06
$649K$750KSEC filing
2026-04-22Amendment
first sale 2024-10-08
$501K—SEC filing
2026-04-22Amendment
first sale 2024-06-27
$1K$1KSEC filing
2026-03-26New offering
first sale 2024-06-27
$1K$1KSEC filing
2025-10-24New offering
first sale 2024-10-08
$251K—SEC filing
2025-10-24New offering
first sale 2024-08-06
$567K$750KSEC filing

How the total is counted: the amount sold on each new offering, added together. Amendments are left out, because an amendment restates an offering already counted. A filing whose figures have not been read yet shows a dash and adds nothing.

Every figure here is read from Nok Therapeutics, Inc.'s own filings with the SEC. The people those filings name are on the team page.

Cite this page

Permanent URL: https://mentionfox.com/company/nok-therapeutics-inc
Last updated 2026-09-26
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4
Nok Therapeutics, Inc. funding history: 8 SEC filings, $818K raised. MentionFox, 2026-09-26. https://mentionfox.com/company/nok-therapeutics-inc